CoV Nucleocapsid (Protein | Antibody | cDNA Clone | ELISA Kit)

All CoV Nucleocapsid reagents are produced in house and quality controlled, including 9 CoV Nucleocapsid Antibody, 16 CoV Nucleocapsid Gene, 7 CoV Nucleocapsid IP Kit, 3 CoV Nucleocapsid Lysate, 3 CoV Nucleocapsid Protein. All CoV Nucleocapsid reagents are ready to use.

CoV Nucleocapsid Protein (3)

    CoV Nucleocapsid Antibody (9)

      CoV Nucleocapsid cDNA Clone (16)


      In expression vector

      SARS-CoV,Strain Tor2

      In expression vector

      In lentiviral vector


      In expression vector

      In expression vector

      CoV Nucleocapsid Lysate (3)

        CoV Nucleocapsid Related Research Area

        CoV Nucleocapsid Background

        Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

        CoV Nucleocapsid References

          1. 1.Van Boheemen S, et al. (2012), MBio. 3(6):e00473-12.
          2. Bisht H. et al., 2004, Proc Natl Acad Sci. 101 (17): 6641-6.
          3. Li W. et al., 2005, Science. 309 (5742): 1864-8.

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.